Biopharma Manufacturers Shouldnât Rush When âGoing Digitalâ
Digitizing manufacturing activities requires strong management and a stepwise approach to implementations [SolStock/Getty Images]
Share
Digitization is a hot topic in biopharma. In recent years, AstraZeneca, Novartis, and Sanofi have each unveiled plans to use data to link drug development, manufacturing, and distribution, citing speed and efficiency as motivation for the investments.
These investments show biopharma is finally recognizing the benefits of digital manufacturing, according to Trent Munro, PhD, professor, University of Queensland, who told
GEN, âIt has turned from hobby to life-blood in recent years. Most established biotechs with commercial manufacturing operations now have a digital technologies group of some sort within the process development or operations group.â